J
Johanna R. Klaus
Researcher at University of Miami
Publications - 4
Citations - 324
Johanna R. Klaus is an academic researcher from University of Miami. The author has contributed to research in topics: Viral load & Insulin resistance. The author has an hindex of 4, co-authored 4 publications receiving 293 citations.
Papers
More filters
Journal ArticleDOI
Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
Barry E. Hurwitz,Johanna R. Klaus,Maria M. Llabre,Alex Gonzalez,Peter J. Lawrence,Kevin Maher,Jeffrey M. Greeson,Marianna K Baum,Gail Shor-Posner,Jay S. Skyler,Neil Schneiderman +10 more
TL;DR: In this article, the effect of high selenium yeast supplementation (200 μg/d) was evaluated in a double-blind, randomized, placebo-controlled trial and the intention-to-treat analyses assessed the effect on HIV-1 viral load and CD4 count after 9 months of treatment.
Journal ArticleDOI
HIV, metabolic syndrome X, inflammation, oxidative stress, and coronary heart disease risk : role of protease inhibitor exposure.
Barry E. Hurwitz,Nancy G. Klimas,Maria M. Llabre,Kevin Maher,Jay S. Skyler,Martin S. Bilsker,Shvawn McPherson-Baker,Peter J. Lawrence,Arthur LaPerriere,Jeffrey M. Greeson,Johanna R. Klaus,Rasha Lawrence,Neil Schneiderman +12 more
TL;DR: It appears that PI medications may exacerbate oxidative stress and hypertriglyceridemia to enhance this risk of myocardial infarction in HIV+ subjects.
Suppression of Human Immunodeficiency Virus Type 1 Viral Load With Selenium Supplementation
Barry E. Hurwitz,Johanna R. Klaus,Maria M. Llabre,Alex Gonzalez,Peter J. Lawrence,Kevin Maher,Jeffrey M. Greeson,Marianna K Baum,Gail Shor-Posner,Jay S. Skyler,Neil Schneiderman +10 more
TL;DR: Daily selenium supplementation can suppress the progression of HIV-1 viral burden and provide indirect improvement of CD4 count and the results support the use of Selenium as a simple, inexpensive, and safe adjunct therapy in HIV spectrum disease.
Journal ArticleDOI
Central Obesity and Insulin Resistance in the Cardiometabolic Syndrome: Pathways to Preclinical Cardiovascular Structure and Function
Johanna R. Klaus,Barry E. Hurwitz,Maria M. Llabre,Jay S. Skyler,Ronald B. Goldberg,Jennifer B. Marks,Martin S. Bilsker,Neil Schneiderman +7 more
TL;DR: The study examined the role of central adiposity and insulin sensitivity and assessed potential relationships with other metabolic indices and measures of cardiac structure and function to suggest predominant pathways through which subclinical metabolic processes may exert pathogenic impact on the heart and vasculature.